Competitive Advantages
- Long-term glucose monitoring
- Improved sensing potentiality
- Reduced chronic diabetic complications
- Will reduce hospitalization rates
Summary
Our inventors have developed an implantable subcutaneous blood glucose level biosensor comprised of a controller, sense antenna, radiating electrode and power source. The radiating electrode can be fabricated from doped 3C-SiC or 4H-SiC. This device is able to continuously monitor glucose levels long-term, thus remaining functional in the body for years. When implanted under the skin, the biosensor will monitor glucose levels and transmit the data to a nearby personal computer via the biosensor’s antenna. The device has the potential to impact the lives of 25.8 million patients in the United States alone living with diabetes. It may also reduce the number of hospitalizations due to complications from poor diabetic management, thereby saving millions of healthcare dollars.
The Proposed Implantable RF Antenna Sensor (In-Vivo) Communicating with an External Receiver
Desired Partnerships
- License
- Sponsored Research
- Co-Development